Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Leukoaraiosis Severity and Outcomes of Endovascular Thrombectomy for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Publisher



Ghozy S1, 2 ; Ahmadzade A3 ; Jazayeri SB3 ; Elfil M4 ; Hasanzadeh A3 ; Tehrani NR3 ; Gorjestani OR3 ; Kobeissei H5 ; Abbas AS6 ; Dmytriw AA7, 8 ; Kadirvel R1, 2 ; Malhotra A9 ; Kallmes DF1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Radiology, Mayo Clinic, Rochester, MN, United States
  2. 2. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States
  3. 3. Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Neurology, University of Miami/Jackson Health System, Miami, FL, United States
  5. 5. Department of Neurosurgery, Corewell Health William Beaumont University Hospital, Royal Oak, MI, United States
  6. 6. Evidence-based Practice Center, Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN, United States
  7. 7. Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, United States
  8. 8. Departments of Medical Imaging and Neurosurgery, Neurovascular Centre, St. Michael’s Hospital, Toronto, ON, Canada
  9. 9. Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, United States

Source: European Radiology Published:2025


Abstract

Background: Endovascular thrombectomy (EVT) is the standard of care for eligible patients with large vessel occlusion (LVO). Yet, little is known regarding the impact of leukoaraiosis (LA) on outcomes following EVT for LVO. Purpose: We conducted a systematic review and meta-analysis to investigate the impact of LA on outcomes following EVT. Materials and methods: A literature search was performed in PubMed, Embase, Scopus, and Web of Science, from inception until January 7, 2024. Patients were categorized into two groups based on the level of LA: one with absent to mild LA (AMLA) and the other with moderate to severe LA (MSLA). The primary outcome of interest was 90-day modified Rankin Scale (mRS) 0–2. Secondary outcomes included symptomatic intracranial hemorrhage (sICH), thrombolysis in cerebral infarction (TICI) score 2b-3, and mortality. Using R software, we calculated pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI). Results: We included 18 studies with 7022 patients. MSLA was associated with lower rates of mRS 0–2 (OR, 0.32 [95% CI: 0.26–0.41]; p < 0.001), similar rates of TICI 2b-3 (OR, 0.91 [95% CI: 0.77–1.07]; p = 0.235) and sICH (OR, 1.18 [95% CI: 0.92–1.51]; p = 0.202), and greater rates of mortality (OR, 2.89 [95% CI: 2.38–3.52]; p < 0.001) compared to AMLA. Conclusion: MSLA is associated with lower rates of mRS 0–2 and worse safety outcomes following EVT for LVO, despite similar rates of TICI 2b-3. Future prospective studies should further study MSLA as a prognosticator following EVT. Key Points: Question Does the severity of LA impact functional and safety outcomes following EVT for acute ischemic stroke due to LVO? Findings Moderate-to-severe LA was associated with lower rates of good functional outcome and higher mortality following EVT, despite similar rates of successful reperfusion and sICH. Clinical relevance LA severity is an independent prognostic factor in EVT outcomes. Identifying patients with moderate-to-severe LA can aid in risk stratification and post-procedural management, optimizing individualized stroke treatment and follow-up strategies. © The Author(s), under exclusive licence to European Society of Radiology 2025.
Experts (# of related papers)
Other Related Docs
29. Prevalence of Preeclampsia and Eclampsia in Iran, Archives of Iranian Medicine (2016)